Bright Minds Biosciences
DRUG
10 hedge funds and large institutions have $399K invested in Bright Minds Biosciences in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, reducing their positions, and 1 closing their positions.
0.12% more ownership
Funds ownership: 0.7% → 0.82% (+0.12%)
9% less funds holding
Funds holding: 11 → 10 (-1)
36% less capital invested
Capital invested by funds: $628K → $399K (-$229K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$87.7K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$4.05K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.42K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$22K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AI
1
AdvisorShares Investments
Bethesda,
Maryland
| $237K | +$87.7K | +16,572 | +40% |
|
|
IC
2
Ikarian Capital
Dallas,
Texas
| $86K | – | – | – |
|
3
Jane Street
New York
| $20K | – | – | – |
|
|
QFA
4
Quattro Financial Advisors
The Woodlands,
Texas
| $17K | – | – | – |
|
|
CCA
5
Checchi Capital Advisers
Beverly Hills,
California
| $14K | – | – | – |
|
6
BlackRock
New York
| $9K | – | – | – |
|
|
BFM
7
Boothbay Fund Management
New York
| $9K | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| $6K | +$4.05K | +765 | +111% |
|
|
9
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$1.42K | +268 | +558% |
|
|
VF
10
Virtu Financial
New York
| – | -$22K | -2,912 | Closed |
|
DRUG Hedge Fund Activity: Q2 2022 in Review
10 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Bright Minds Biosciences (DRUG) for Q2 2022, worth a combined $399K — down 36% from $628K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of DRUG and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 3 added.
The largest buyer was AdvisorShares Investments, adding an estimated $87.7K. The largest seller was Virtu Financial, exiting entirely with an estimated $22K sold.
- 10 institutional investors held Bright Minds Biosciences (DRUG) as of Q2 2022, down from 11 in Q1 2022.
- Funds reported $399K of Bright Minds Biosciences stock for Q2 2022, down 36% quarter-over-quarter.
- 0 funds opened new Bright Minds Biosciences positions in Q2 2022 and 1 closed out, a net change of -1 holder.
- The largest Bright Minds Biosciences buyer in Q2 2022 was AdvisorShares Investments, an estimated $87.7K added.
- The largest Bright Minds Biosciences seller in Q2 2022 was Virtu Financial, an estimated $22K sold.
Based on aggregated 13F filings for Q2 2022.